Today: September 20, 2024
Today: September 20, 2024

Edgar Bronfman Jr. still pursuing a deal for Paramount, Axios reports

FILE PHOTO: Edgar Bronfman Jr., Chairman, Endeavor Global, speaks during the Milken Institute's 22nd annual Global Conference in Beverly Hills, California
July 30, 2024
Reuters

(Reuters) -Former Warner Music chairman Edgar Bronfman Jr. is still in talks with bankers about a potential bid for Paramount Global's parent, National Amusements, Axios reported on Tuesday, citing sources.

Read More

Related

Business|Entertainment|Food|Sports

Kelce Cereal: Travis Kelce and Jason Kelce's cereal hits the shelves in Kansas City

Kelce Cereal: Travis Kelce and Jason Kelce's cereal hits the shelves in Kansas City

Kelce Cereal: Travis Kelce and Jason Kelce's cereal hits the shelves in Kansas City
Business|Crime|Finance|Technology

"Pig butchering," an account-draining cryptocurrency scam, prompts FBI warning

"Pig butchering," an account-draining cryptocurrency scam, prompts FBI warning

"Pig butchering," an account-draining cryptocurrency scam, prompts FBI warning
Business|News|Technology

Facebook loses jurisdiction appeal in Kenyan court paving the way for moderators' case to proceed

Meta, Facebook’s parent company, has lost an appeal in a Kenyan labor court

Facebook loses jurisdiction appeal in Kenyan court paving the way for moderators' case to proceed
Share This

Popular

Business|Economy|Finance|Stock Markets

Investor focus turns to data, election, earnings after Fed cut

Investor focus turns to data, election, earnings after Fed cut
Business|Finance|News|Technology

Boeing furloughs begin on Friday for thousands in Pacific Northwest

Boeing furloughs begin on Friday for thousands in Pacific Northwest
Business|Finance|Health

Cardinal Health to acquire Integrated Oncology Network for $1.12 billion

Cardinal Health to acquire Integrated Oncology Network for $1.12 billion
Business|Economy|Finance|Health|News

Challenge to US drug price negotiation program revived by appeals court

Challenge to US drug price negotiation program revived by appeals court